Application of CT-based foundational artificial intelligence and radiomics models for prediction of survival for lung cancer patients treated on the NRG/RTOG 0617 clinical trial
BJR|Open · 12.12.2023 · 6 (1)
DOI: 10.1093/bjro/tzae038 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJR|Open, online erschienen am 06.11.2024. Verfasst von Taman Upadhaya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California, 90048, United States. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Garber Award for Cancer Research.
Themen: Künstliche Intelligenz in der Pflege, Onkologische Pflege
Abstract (Originalsprache)
Objectives
To apply CT-based foundational artificial intelligence (AI) and radiomics models for predicting overall survival (OS) for patients with locally advanced non-small cell lung cancer (NSCLC).
Methods
Data for 449 patients retrospectively treated on the NRG Oncology/Radiation Therapy Oncology Group (RTOG) 0617 clinical trial were analyzed. Foundational AI, radiomics, and clinical features were evaluated using univariate cox regression and correlational analyses to determine independent predictors of survival. Several models were fit using these predictors and model performance was evaluated using nested cross-validation and unseen independent test datasets via area under receiver-operator-characteristic curves, AUCs.
Results
For all patients, the combined foundational AI and clinical models achieved AUCs of 0.67 for the Random Forest (RF) model. The combined radiomics and clinical models achieved RF AUCs of 0.66. In the low-dose arm, foundational AI alone achieved AUC of 0.67, while AUC for the ensemble radiomics and clinical models was 0.65 for the support vector machine (SVM). In the high-dose arm, AUC values were 0.67 for combined radiomics and clinical models and 0.66 for the foundational AI model.
Conclusions
This study demonstrated encouraging results for application of foundational AI and radiomics models for prediction of outcomes. More research is warranted to understand the value of ensemble models toward improving performance via complementary information. Advances in knowledge Using foundational AI and radiomics-based models we were able to identify significant signatures of outcomes for NSCLC patients retrospectively treated on a national cooperative group clinical trial. Associated models will be important for application toward prospective patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California, 90048, United States.
- Department of Radiation Oncology, Henry Ford Hospital, Detroit, Michigan, 48202, United States.
ORCID-Profile: Taman Upadhaya
Förderung
- Garber Award for Cancer Research
Zitieren
APA
Upadhaya, T., Chetty, I. J., McKenzie, E. M., Bagher-Ebadian, H., & Atkins, K. M. (2023). Application of CT-based foundational artificial intelligence and radiomics models for prediction of survival for lung cancer patients treated on the NRG/RTOG 0617 clinical trial. BJR|Open, 6(1). https://doi.org/10.1093/bjro/tzae038
Vancouver
Upadhaya T, Chetty IJ, McKenzie EM, Bagher-Ebadian H, Atkins KM. Application of CT-based foundational artificial intelligence and radiomics models for prediction of survival for lung cancer patients treated on the NRG/RTOG 0617 clinical trial. BJR|Open. 2023;6(1). doi:10.1093/bjro/tzae038
BibTeX
@article{Upadhaya2023,
author = {Upadhaya, Taman and Chetty, Indrin J and McKenzie, Elizabeth M and Bagher-Ebadian, Hassan and Atkins, Katelyn M},
title = {Application of CT-based foundational artificial intelligence and radiomics models for prediction of survival for lung cancer patients treated on the NRG/RTOG 0617 clinical trial},
journal = {BJR|Open},
year = {2023},
volume = {6},
number = {1},
doi = {10.1093/bjro/tzae038}
}
EUVIMED